'FabiSpray': Glenmark Launches Nitric Oxide Nasal Spray For Treatment Of Adult COVID-19 Patients
Swarajya StaffFeb 9, 2022 01:03 PM +05:30 IST
After DCGI's Nod, Glenmark Launches Anti-Viral Drug FabiFlu For Treatment Of Mild To Moderate Covid-19 PatientsSwarajya StaffJun 20, 2020 05:08 PM +05:30 IST
Glenmark To Begin Phase 3 Clinical Trial On Combo Of Two Antiviral Drugs In Moderate Covid-19 PatientsSwarajya StaffMay 26, 2020 01:42 PM +05:30 IST